Relevance of N-nitrosamines to oesophageal cancer in China. 1991

S H Lu, and S X Chui, and W X Yang, and X N Hu, and L P Guo, and F M Li
Cancer Institute, Chinese Academy of Medical Sciences, Beijing.

Oesophageal cancer occurs at a very high frequency in certain areas of China, especially in Linxian county, Henan province. Previous studies suggested that N-nitroso compounds play a causative role. In order to study further the exposure of Linxian inhabitants, the intake of N-nitrosamines in the diet was determined. The total daily intake of volatile nitrosamines and of N-nitroso-N-methylbenzylamine (NMBzA) was higher in Linxian than in two other counties. NMBzA can induce cancer in animal and human oesophageal epithelium. Human fetal oesophageal epithelia were cultured with NMBzA for 4 h, and eight monkeys were treated with NMBzA. High-molecular-weight DNA extracted from explants and from the oesophageal epithelia of monkeys induced malignant transformation of NIH 3T3 cells. Alu and monkey-specific repeat sequences were present in transformed cells, and H-ras was found in the transforming DNA. Human fetal oesophageal epithelium cultured with NMBzA was transplanted into the mesentery of BALB/c nude mice. Tumours were found after eight months; and the Alu sequence was present in DNA extracted from tumours induced by NMBzA, showing that the tumours were of human origin. The results provide direct evidence that NMBzA is carcinogenic in human oesophageal epithelium and that N-nitrosamines are one of the causative factors of oesophageal cancer in Linxian county.

UI MeSH Term Description Entries
D009602 Nitrosamines A class of compounds that contain a -NH2 and a -NO radical. Many members of this group have carcinogenic and mutagenic properties. Nitrosamine
D009857 Oncogenes Genes whose gain-of-function alterations lead to NEOPLASTIC CELL TRANSFORMATION. They include, for example, genes for activators or stimulators of CELL PROLIFERATION such as growth factors, growth factor receptors, protein kinases, signal transducers, nuclear phosphoproteins, and transcription factors. A prefix of "v-" before oncogene symbols indicates oncogenes captured and transmitted by RETROVIRUSES; the prefix "c-" before the gene symbol of an oncogene indicates it is the cellular homolog (PROTO-ONCOGENES) of a v-oncogene. Transforming Genes,Oncogene,Transforming Gene,Gene, Transforming,Genes, Transforming
D002681 China A country spanning from central Asia to the Pacific Ocean. Inner Mongolia,Manchuria,People's Republic of China,Sinkiang,Mainland China
D004032 Diet Regular course of eating and drinking adopted by a person or animal. Diets
D004938 Esophageal Neoplasms Tumors or cancer of the ESOPHAGUS. Cancer of Esophagus,Esophageal Cancer,Cancer of the Esophagus,Esophagus Cancer,Esophagus Neoplasm,Neoplasms, Esophageal,Cancer, Esophageal,Cancer, Esophagus,Cancers, Esophageal,Cancers, Esophagus,Esophageal Cancers,Esophageal Neoplasm,Esophagus Cancers,Esophagus Neoplasms,Neoplasm, Esophageal,Neoplasm, Esophagus,Neoplasms, Esophagus
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012306 Risk The probability that an event will occur. It encompasses a variety of measures of the probability of a generally unfavorable outcome. Relative Risk,Relative Risks,Risk, Relative,Risks,Risks, Relative

Related Publications

S H Lu, and S X Chui, and W X Yang, and X N Hu, and L P Guo, and F M Li
November 1984, Carcinogenesis,
S H Lu, and S X Chui, and W X Yang, and X N Hu, and L P Guo, and F M Li
January 1994, Journal of toxicology and environmental health,
S H Lu, and S X Chui, and W X Yang, and X N Hu, and L P Guo, and F M Li
January 1989, Cancer surveys,
S H Lu, and S X Chui, and W X Yang, and X N Hu, and L P Guo, and F M Li
November 1968, Lancet (London, England),
S H Lu, and S X Chui, and W X Yang, and X N Hu, and L P Guo, and F M Li
January 1991, IARC scientific publications,
S H Lu, and S X Chui, and W X Yang, and X N Hu, and L P Guo, and F M Li
January 1989, Lancet (London, England),
S H Lu, and S X Chui, and W X Yang, and X N Hu, and L P Guo, and F M Li
January 1991, Critical reviews in toxicology,
S H Lu, and S X Chui, and W X Yang, and X N Hu, and L P Guo, and F M Li
January 1991, IARC scientific publications,
S H Lu, and S X Chui, and W X Yang, and X N Hu, and L P Guo, and F M Li
March 1989, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
S H Lu, and S X Chui, and W X Yang, and X N Hu, and L P Guo, and F M Li
July 1975, British medical journal,
Copied contents to your clipboard!